Vascular Solutions to Present at the 2010 Stifel Nicolaus Healthcare Conference

MINNEAPOLIS--(BUSINESS WIRE)--Vascular Solutions, Inc. (Nasdaq:VASC) today announced that the Company is scheduled to present at the 2010 Stifel Nicolaus Healthcare Conference in Boston on Wednesday, September 15 at 10:55am (EST).

Howard Root, Chief Executive Officer of Vascular Solutions, will deliver the Company’s presentation. To hear the live audio webcast and view the slides of the Vascular Solutions’ presentation, go to the investor relations page of the Company’s web site http://www.vascularsolutions.com and click on the “IR Conferences” icon a few minutes prior to start time to download any necessary software.

About Stifel Nicolaus

Stifel Financial Corp. (NYSE: SF) is a financial services holding company headquartered in St. Louis, Missouri, that conducts its banking, securities and financial services business through several wholly-owned subsidiaries. Stifel clients are primarily served in the U.S. through 310 offices in 43 states, and the District of Columbia through Stifel, Nicolaus & Company, Incorporated and Thomas Weisel Partners LLC, and in Canada through Stifel Nicolaus Canada Inc. Clients in the United Kingdom and Europe are served through offices of Stifel Nicolaus Limited and Thomas Weisel Partners International Limited. Each of the broker-dealer affiliates provide securities brokerage, investment banking, trading, investment advisory, commercial and retail banking and related financial services to individual investors, professional money managers, businesses, and municipalities. Stifel Bank & Trust offers a full range of consumer and commercial lending solutions. To learn more about Stifel, please visit the company’s web site at www.stifel.com.

About Vascular Solutions

Vascular Solutions, Inc. is an innovative medical device company focused on developing and delivering customized clinical solutions for coronary and peripheral vascular procedures. The company’s product line consists of over 50 products in three categories: catheter products (used in diagnosing and treating vascular disease), hemostat products (used in the control of bleeding during vascular procedures), and vein products (used in the treatment of varicose veins). Vascular Solutions delivers its products to interventional cardiologists, interventional radiologists and vascular surgeons performing percutaneous procedures through its direct U.S. sales force and international distributor network.

The information in this press release contains forward-looking statements that involve risks and uncertainties. Our actual results could differ materially from those anticipated in these forward-looking statements. Important factors that may cause such differences include those discussed in our Annual Report on Form 10-K for the year ended December 31, 2009 and other recent filings with the Securities and Exchange Commission. The risks and uncertainties include, without limitation, risks associated with the need for adoption of our new products, limited working capital, lack of sustained profitability, exposure to intellectual property claims, exposure to possible product liability claims, the development of new products by others, doing business in international markets, limited manufacturing experience, the availability of third party reimbursement, and actions by the FDA.

For further information, connect to www.vascularsolutions.com.